Pelvic Floor Muscle Training in the Treatment of Erectile Dysfunction
NCT ID: NCT05385822
Last Updated: 2022-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2022-05-01
2025-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Theoretically, a strengthening of the pelvic floor muscles can help increase the intracavernous pressure and thereby the hardness of the erection. Furthermore, tense pelvic floor muscles can help compress pelvic veins and reduce blood flow away from the penis which prolongs the erection. Finally, it is possible that pelvic floor muscle training can contribute to an increased blood supply to the pelvic floor and the penis which will have positive effects in relation to both the integrity of the penile tissue and the physiological erection mechanism itself.
This study aims to investigate the effect of pelvic floor muscle training in men with erectile dysfunction.
The study hypothesis is that pelvic floor training can provide a clinically significant improvement in the erection function at individual patient level
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low Intensity Extracorporeal Shock Wave Therapy (Li-ESWT) for Erectile Dysfunction
NCT04720755
Evaluate the Clinical Efficacy of Precious Metal Fiber Textile (Germanium Titanium π Element) for Erectile Dysfunction
NCT03359265
PRP for the Treatment of Erectile Dysfunction (ED)
NCT04350125
Treatment of Peyronie's Disease With Platelet-Rich Plasma
NCT06789510
Treatment of Erectile Dysfunction I
NCT01037244
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
The control group will not recieve any training in the trial period but will have to answer the same questionnaires on erectile function (IIEF-EF) and international prostate symptom score (IPSS).
No interventions assigned to this group
Pelvic Floor Muscle Training
Participants who are randomized to pelvic floor training will then undergo instruction in the anatomy, function and training of the pelvic floor muscles.
Pelvic Floor Muscle Training
* Isolated, quite light tension in the pelvic floor 10 times, where the tension is released immediately
* Constant tension for 30 seconds twice, with a 30-second pause
* Total relaxation for 1 minute They must perform these exercises once a day during the trial period of 3 months
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pelvic Floor Muscle Training
* Isolated, quite light tension in the pelvic floor 10 times, where the tension is released immediately
* Constant tension for 30 seconds twice, with a 30-second pause
* Total relaxation for 1 minute They must perform these exercises once a day during the trial period of 3 months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* IIEF-EF score \< 25
* In a stable heterosexual relationship in minimum of 3 months (since all questionnaires are only validated for heterosexuals)
Exclusion Criteria
* Traumatic nerve damage
* Diabetes
* Previous surgery or radiotherapy in the pelvic region
* Nerve disorders that prevent nerve connection to the pelvic floor muscles
* Severe heart disease in the form of unstable angina, NYHA class \> II heart failure, uncontrolled arrhythmia or severe symptomatic and/or severe valvular disease
* Use of anti-androgen drugs Peyronie's disease and/or previous cases of priapism
* Alcohol overconsumption (more than 21 items per week)
30 Years
70 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Herlev and Gentofte Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emil Durukan
Medical Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Urological Research Unit
Herlev, Capital Region, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRE-Train Project
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.